Loading...
Market
Impact of the lawsuit on Express Scripts' stock price by June 30, 2025?
2
Resolution / Starting Odds
Increase by more than 10% • 25%
Decrease by more than 10% • 25%
No significant change (within ±10%) • 25%
Other • 25%
Stock market data from financial platforms like Bloomberg or Yahoo Finance
Story
Express Scripts Sues FTC, Lina Khan for Defamation Over Drug Pricing Report
Sep 17, 2024, 11:22 AM
Express Scripts, a unit of Cigna and one of the largest pharmacy benefit managers in the United States, has filed a lawsuit against the Federal Trade Commission (FTC). The lawsuit demands the retraction of a recent FTC report that criticized companies negotiating drug prices, alleging that the report's conclusions are defamatory. The FTC's report, released in July, claimed that prescription middlemen, such as Express Scripts, contribute to higher drug costs for consumers and harm pharmacists. Express Scripts argues that the report contains misleading claims about the industry. The lawsuit specifically accuses FTC Chair Lina Khan of defamation.
View original story
Similar markets
Increase by more than 10% • 25%
Decrease by more than 10% • 25%
Change by less than 10% • 25%
Remain the same • 25%
Express Scripts wins • 25%
FTC wins • 25%
Settlement reached • 25%
Case dismissed • 25%
Yes • 50%
No • 50%
Stock price increases by over 10% • 25%
Stock price changes between -10% and +10% • 25%
Stock price decreases by over 10% • 25%
No significant change • 25%
Yes • 50%
No • 50%
Stock price increases by over 10% • 25%
Stock price decreases by over 10% • 25%
Stock price remains within 10% range • 25%
Stock is delisted • 25%
Express Scripts fined • 25%
Express Scripts settles out of court • 25%
Express Scripts found not guilty • 25%
Case dismissed or no action taken • 25%
Stock price increases • 25%
Stock price decreases • 25%
Stock price remains stable • 25%
Stock price highly volatile • 25%
Increase by more than 10% • 25%
Increase by less than 10% • 25%
Decrease by less than 10% • 25%
Decrease by more than 10% • 25%
UnitedHealth Group stock rises • 25%
Cigna Group stock rises • 25%
CVS Health stock rises • 25%
All stocks fall • 25%
Increase by more than 5% • 25%
Decrease by more than 5% • 25%
No significant change • 25%
Increase or decrease by less than 5% • 25%
Plaintiff's stock rises • 25%
Defendant's stock rises • 25%
Both stocks rise • 25%
Both stocks fall • 25%